Quantamental Technologies’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,901
Closed -$269K 526
2023
Q2
$269K Sell
1,901
-1,159
-38% -$186K 0.11% 316
2023
Q1
$515K Buy
+3,060
New +$546K 0.28% 112
2020
Q4
Sell
-2,070
Closed -$305K 241
2020
Q3
$305K Buy
+2,070
New +$296K 0.23% 141
2019
Q4
Sell
-2,943
Closed -$226K 1135
2019
Q3
$226K Buy
+2,943
New +$257K 0.07% 462
2019
Q2
Sell
-3,672
Closed -$217K 1750
2019
Q1
$217K Sell
3,672
-1,724
-32% -$99.1K 0.1% 346
2018
Q4
$285K Buy
+5,396
New +$316K 0.17% 170

Other funds holding RGEN

Quantamental Technologies's RGEN Position: Q3 2023 in Review

Quantamental Technologies sold out of Repligen (RGEN) in Q3 2023, closing a stake of 1,901 shares — an estimated $269K sold.

Quantamental Technologies first reported a position in RGEN in Q4 2018 and held it in 6 quarters. The position peaked at $515K in Q1 2023. 440 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Quantamental Technologies reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 1,901 Repligen shares in Q3 2023, an estimated $269K.
  • Quantamental Technologies first reported a position in Repligen in Q4 2018 and held it in 6 quarters.
  • Quantamental Technologies's Repligen position peaked at $515K in Q1 2023.
  • 440 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.